S&P also lowered the rating to “AA-/A-1+” from “AA/A-1+” on North Broward Hospital District’s series 2005A, 2007 and 2008A bonds.
The outlook is negative, reflecting S&P’s expectation that the health system’s operational challenges will continue amidst the struggle to find permanent leadership.
“The lower rating and negative outlook reflect continued weak operating results, thin cash flow and the continued void in permanent senior leadership, with many positions filled on an interim basis during a period of significant challenges and heightened scrutiny,” said Stephen Infranco, an S&P Global Ratings analyst.
North Broward Hospital District does business as Broward Health.
More articles on healthcare finance:
Children’s Hospital of LA to rename inpatient floor after donation from Panda Express
Massachusetts Gov. Charlie Barker urges lawmakers to reconsider Medicaid reform
Nasdaq, S&P see record highs thanks to healthcare, tech
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
